Healthy lifestyle reduces metabolic syndrome risk for cancer survivors

This article originally appeared here.
Share this content:
Healthy Lifestyle Cuts Metabolic Syndrome Risk in CA Survivors
Healthy Lifestyle Cuts Metabolic Syndrome Risk in CA Survivors

(HealthDay News) -- For childhood cancer survivors, following a heart-healthy lifestyle is associated with a reduced risk of metabolic syndrome (MetS), according to a study published online July 28 in Cancer.

Webb A. Smith, from St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues characterized lifestyle habits and associations with MetS among childhood cancer survivors. Participants included 1,598 childhood cancer survivors who were 10 or more years from diagnosis and completed medical and laboratory tests and a food frequency questionnaire. Lifestyle habits were characterized according to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations, with those who met four or more of seven recommendations classified as having followed guidelines.

The researchers found that 31.8 percent of participants met the criteria for MetS and 27.0 percent followed WCRF/AICR guidelines. MetS was 2.4 times more likely for females and 2.2 times more likely for males who did not follow guidelines, compared with those who followed guidelines.

"Adherence to a heart-healthy lifestyle is associated with a lower risk of MetS among childhood cancer survivors," the authors write. "There is a need to determine whether lifestyle interventions prevent or remediate MetS in childhood cancer survivors."

One author disclosed financial ties to Novo Nordisk.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs